Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Bringing together the academic drug discovery community



The newly formed Academic Drug Discovery Consortium (ADDC) aims to support the growing numbers of university centres engaged in drug discovery that have emerged in response to recent changes in the drug discovery ecosystem.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. Arrowsmith, J. Trial watch: Phase II failures: 2008–2010. Nature Rev. Drug Discov. 10, 328–329 (2011).

    CAS  Article  Google Scholar 

  2. Arrowsmith, J. Trial watch: Phase III and submission failures: 2007–2010. Nature Rev. Drug Discov. 10, 87 (2011).

    CAS  Article  Google Scholar 

  3. Paul, S. M. et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nature Rev. Drug Discov. 9, 203–214 (2010).

    CAS  Article  Google Scholar 

  4. Begley, C. G. & Ellis, L. M. Drug development: Raise standards for preclinical cancer research. Nature 483, 531–553 (2012).

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Barbara S. Slusher.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Related links

Related links



The NCATS Budget

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Slusher, B., Conn, P., Frye, S. et al. Bringing together the academic drug discovery community. Nat Rev Drug Discov 12, 811–812 (2013).

Download citation

  • Published:

  • Issue Date:

  • DOI:

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing